by Victor Kohn, Steve Watson, and Kent Chan, Capital Group
As nearly three years of lockdowns come to an end in China, will 2023 be a turning point for equity investors?
Without a doubt, China’s equity risk premium is higher than other markets. As investment professionals with more than 25 years of experience investing in China, we believe the higher premium is due to the government’s repeated intervention and influence in the economy and markets, as well as geopolitical uncertainty. We also recognize that China’s economic recovery could be uneven and trade-related tensions with the U.S. will likely persist.
However, China’s equities markets have been rallying this year on the country’s abrupt departure from strict COVID policies. Some sectors have been buoyed by more supportive measures for the property market and encouraging regulatory developments for technology companies. We’ve learned from experience that volatility can mask buying opportunities in China. We believe this could be one of those times, particularly for select companies well-positioned for an economic rebound, but also for those that remain aligned with the Common Prosperity goals of the administration.
Here are a few themes to consider for investing in China and why we are constructive:
1. Reopening could be a positive catalyst for valuations
China’s departure from its zero-COVID policy removes a headwind to stocks and could be a catalyst for a positive rerating of Chinese equities. The MSCI China Index has already surged more than 50% (as of January 23) after reaching a multiyear low October 31, 2022, and we believe it has more room to run. Valuations for almost all sectors are still trading below their 10-year average on a consensus price-to-earnings (P/E) basis for the next 12 months. We don’t anticipate the market will rally indefinitely, but we sense downside risks have lessened, given that sentiment had become so dire since 2021.
The ability for people to move more freely should trigger a change in consumer behaviour and lead to a recovery in domestic consumption. Beneficiaries of this shift will likely be hotel companies, online travel firms, airport operators and luxury goods makers. Airports are busy again as people seek to travel inside and outside the country. There’s been a surge in hotel bookings in China’s larger cities, and consumers are flocking back to shopping malls.
Many sectors trade at steep discounts
Sources: MSCI, RIMES. Forward price-to-earnings ratio reflects the current share price relative to the consensus estimate for earnings per share on a forward 12-month basis. Data as of November 30, 2022.
Increased mobility may also benefit certain financial services providers whose sales agents rely on face-to-face meetings to drive new business. Casino operators in Macau, where travel is opening up after heavy restrictions, could benefit too.
We think a cyclical recovery could boost the outlook for China’s larger banks, which on a P/E basis currently trade for three or four times consensus earnings expectations for the next 12 months. Valuations for Chinese banks have been depressed for many years. But they compressed further in 2022 on China’s weak growth and liquidity crunch in the property market.
2. Government is committed to stabilizing the property market
As part of its message that “housing is for living, not for speculation,” Beijing has sought to contain the rapid appreciation in residential property prices and reduce excess leverage. However, its various policy decisions have not always had the intended outcome. Many property developers are struggling financially, some have defaulted on debt payments, and homebuyers have become more cautious.
Recent actions have made it clear that the government recognizes it has to fix the property sector, which represents about 25% of GDP and roughly 60% of household balance sheets. Authorities have provided hundreds of billions of dollars to help complete unfinished projects, loosened down-payment requirements and lowered mortgage rates. These measures, among others, should help restore consumer confidence and minimize bankruptcies. We think government leaders have little choice but to keep introducing new polices to bolster the property market until they can rectify the situation.
Homebuying in China has slumped
Source: Capital Group, National Bureau of Statistics of China, Refinitiv Datastream. China home sales above are represented by the quarterly sales volume of commercial residential buildings in current prices. As of December 31, 2022.
After what is likely to be wave of consolidation and limitations on development, the property market will likely become a smaller part of the economy longer term. It should also be operated more sensibly and far less on speculation. Volume growth will likely be more measured and selling prices more constrained to make housing more affordable. This could be an opportunity for higher quality developers who have maintained stronger balance sheets to gain market share and consolidate their leadership positions.
3. Regulatory fog is clearing over China’s tech sector
The most stringent policy measures to curb overreach in China’s technology sector may be behind us. These were aimed at controlling excesses in the private economy and curbing monopolistic behaviour. Moving forward, it’s clear growth for technology companies will be more constrained due to regulation but also because the industry has matured.
Valuations for internet-related companies remain depressed by historical standards. The downside seems more limited now assuming conservative earnings growth. But we do not expect a significant rerating for these companies, because revenue growth rates probably won’t reach 30% to 40% again.
On the upside, the regulatory environment appears to be improving. For example, Tencent and NetEase have received long-awaited approvals for new video game licenses. Ant Group, whose high-profile initial public offering was halted in 2020, was recently allowed to start raising capital from new investors.
Government regulators reportedly plan to take special 1% equity stakes (known as “golden shares”) in units of Tencent and Alibaba, similar to those taken at TikTok owner ByteDance and Weibo, China’s version of Twitter. We think this signals that Beijing’s rectification process is nearing an end.
How much risk is priced in? Tech valuations have compressed
MSCI, RIMES. Forward price-to-earnings ratio reflects the current share price relative to the consensus estimate for earnings per share on a forward 12-month basis. Data as of November 30, 2022.
China’s internet giants have narrowed their business focus and adjusted their cost structures by exiting business lines and laying off employees. They’ve also made a massive shift in expansion and growth strategies. Instead of seeking out large-scale acquisitions, they have divested from equity stakes in other tech firms and used excess cash to buy back shares or pay special dividends to shareholders.
We believe that innovation will also continue to drive growth. China’s video game platforms, payment systems and e-commerce have been areas of tremendous innovation over the past decade, and this should continue to drive growth. As many companies find a new rhythm in the evolved regulatory regime, we expect new technologies to be new sources of revenues and earnings.
4. Beijing needs more growth to support policy agenda
It’s our belief that China wants a growing and dynamic economy characterized by a significant degree of innovation. We believe Communist Party leaders know this cannot be accomplished by state-owned businesses alone and that private enterprise is needed to achieve long-term economic goals.
China’s equity risk premium (an excess return that investing in stocks can provide over a risk-free rate typically represented by Treasuries) is higher than other markets, but there are reasons to consider investing: China is a large domestic market. Its population is getting older and wealthier, creating the need for a better health care system and a wide range of consumer and financial services. Swings in market sentiment have not changed these realities in our view.
China’s biopharmaceutical industry, which is closely aligned with the government’s domestic policy agenda, is a longer term potential opportunity with a long runway for growth. Several well-capitalized companies are developing innovative drugs that have the potential to be sold around the world. Multinationals have also partnered with Chinese firms such as BeiGene and Innovent to develop new drugs and sell them in China’s large market.
China also wants to bolster its manufacturing prowess and retain dominance in certain areas of the global supply chain, such as electric vehicles (EVs). China has become a global leader in battery development, a key supplier of other materials and a large EV manufacturer in its own right.
Stock picking in China has been crucial over the past decade
MSCI, RIMES. Data reflects price level on net basis. As of December 31, 2022.
5. A reset in U.S-China relations
There have been steps in the right direction to help reset relations between the U.S. and China, which could help alleviate pressure on Chinese assets.
Presidents Joe Biden and Xi Jinping held constructive talks at November’s G-20 meeting. U.S. audit regulators were granted deeper access to inspect the books of Chinese companies that trade on U.S. stock exchanges, helping ease concerns that the companies could be delisted. Chinese biopharmaceutical companies were also removed from the U.S. Commerce Department’s unverified list regarding access to facility inspections.
Of course, China’s strategy and approach to Taiwan remain the biggest unknown and risk.
Overall direction looking more positive
We think we are past the point of peak pessimism on China. The reopening of the economy will be a catalyst to stimulate domestic consumption, which should provide a boost to many other areas, even though the overall nominal GDP growth rate may remain muted. From our experience investing in China, the bull phase is not as strong as investor enthusiasm, and the bottom is not as deep as investors fear.
No doubt there will be ongoing geopolitical and economic uncertainties, but as the world’s second largest economy reopens, we also see many investment opportunities. Companies tapping into travel, entertainment, higher quality goods, better health care, technology innovation and renewable energy could be long-term beneficiaries. Current valuations provide good entry points for many of them. But in China as much as in any market, fundamental research and a deep knowledge of companies are a must for successful investing and determining the appropriate level of exposure.
Victor Kohn is an equity portfolio manager with 38 years of industry experience (as of 12/31/22). He holds an MBA from Stanford and master’s and bachelor’s equivalent degrees in industrial engineering from the Universidad de Chile. He also holds the Chartered Financial Analyst® designation.
Steve Watson is an equity portfolio manager with 34 years of investment experience (as of 12/31/22). He has an MBA and an MA in French studies from New York University as well as a bachelor's in French from the University of Massachusetts.
Kent Chan is an equity investment director with 31 years of industry experience (as of 12/31/22). He holds a bachelor’s degree in political economics from the University of California, Berkeley.
Copyright © Capital Group